Sleep, stroke, and vascular dementia

Antonio Culebras MD FAAN FAHA FAASM

Sleep Disorders

Updated 10.14.2024
Released 10.11.1993
Expires For CME 10.14.2027

Sleep, stroke, and vascular dementia

Author: Antonio Culebras MD FAAN FAHA FAASM

See Contributor Disclosures

Sleep, stroke, and vascular dementia

In This Article

Quick Link

Introduction

Overview

In this article, the author highlights the importance of obstructive sleep apnea as a risk factor for stroke and vascular dementia. Rehabilitation and recovery of stroke are less successful in the presence of sleep apnea. Habitual short and long sleep durations, long-standing night shift work, and periodic leg movements of sleep negatively affect cerebrovascular morbidity and mortality. Vascular dementia may be a complication of uncontrolled sleep apnea with hypoxemia. Inroads are made into the concept of ischemic preconditioning, a potential therapeutic option that might be relevant in moderate to severe sleep apnea and has been initiated in clinical trials.

Key points

	• Obstructive sleep apnea is the most common sleep disorder and is a major risk factor for stroke and transient ischemic attack.
	• Central sleep apnea is also a risk factor for ischemic stroke.
	• Wake-up stroke may be related to severe sleep apnea, right-to-left shunt provoked by long-duration apnea events in patients with patent foramen ovale, or atrial fibrillation in patients with sleep apnea.
	• Vascular dementia may be a complication of uncontrolled sleep apnea with nocturnal hypoxemia.

Historical note and terminology

Sleep apnea is the major sleep disorder associated with stroke (26; 24; 90). Gastaut described obstructive sleep apnea and pointed out its relevance for the pathogenesis of Pickwickian syndrome (35). The Pickwickian syndrome (now termed obesity hypoventilation syndrome) was recognized and named in 1956 (11). The association of sleep apnea with stroke was stressed with the discovery of snoring as a risk factor for stroke, the high incidence of sleep apnea in patients with stroke (48), and a significant peak for stroke incidence in the morning hours (65). In 2008, the American Heart Association highlighted in a scientific statement concepts and evidence important to understanding the interactions between sleep apnea and vascular disease (93).

Clinical manifestations

Presentation and course

It may be difficult to differentiate the sleepiness and other symptoms associated with obstructive sleep apnea from such acute manifestations of cerebrovascular disease as lethargy, apathy, and neglect, particularly with strokes in specific locations, such as bilateral paramedian thalamic infarctions. The spouse of a stroke victim may describe a lack of energy, falling asleep during activities, and fatigue. Additional questioning may elicit a history of snoring (with repetitive respiratory interruptions), restless sleep, nonrestorative sleep, and weight gain before or following the stroke. Weakness of pharyngeal dilator muscles following a stroke may contribute to elevated resistance in the upper airway, which is common in obstructive sleep apnea. Dysphagia and dysarthria in patients with acute stroke are generally associated with sleep apnea (25). One study showed that dysphagia severity was associated with obstructive sleep apnea severity, and this association was independent of sex, modified Barthel index, and body mass index (33). However, stroke-induced dysphagia was not associated with central sleep apnea or overall sleep-disordered breathing.

Twenty-four-hour ambulatory blood pressure monitoring reveals that arterial pressure ordinarily falls during nocturnal sleep 10% to 20% below that of diurnal waking. However, 50% of patients with acute hemispheric ischemic stroke are "nondippers" (a fall of less than 10%), as are 23% of patients with lacunar infarct versus 7% of controls (54). In general, target organ damage is greater in nondippers than in dippers, even though they may have comparable 24-hour mean blood pressure levels. Interestingly, both "reverse dipping" and "extreme dipping" (greater than 20% nocturnal reduction) are independent risk factors for multiple silent lacunar infarcts in elderly Japanese patients with hypertension (50).

The incidence of periodic central sleep apnea during sleep (Cheyne-Stokes) in patients with stroke has been reported to be as high as 41% (91) (a smaller, earlier study cited 53%). Furthermore, data from the Sleep Heart Health Study reveal that the presence of central sleep apnea is associated with MRI evidence of white matter ischemic changes or frank infarcts (81), and central sleep apnea is an independent risk factor for stroke in elderly patients (70).

In a study of 1346 patients with relatively mild stroke with an NIHSS of 6 or lower, only 1.4% met the criteria for central sleep apnea (88). However, the median time from stroke recognition to portable respiratory recording was 13 days, a length of time superior to the interval of 48 to 72 hours reported by other authors (75). The timing of the stroke may be of the essence as central sleep apnea appears to be more common during the hyperacute stage of stroke (23).

Sleep disruption and nonrestorative sleep are ubiquitous following hemispheric strokes, as is daytime sleepiness, even in the absence of sleep apnea. The presence of sleep continuity disturbances in the acute phase of stroke may represent a risk factor for poor outcomes (100). In a rat model of middle cerebral artery ischemic stroke, sleep deprivation hindered functional recovery and impaired synaptogenesis and cell proliferation (109). Lastly, poststroke depression may affect up to one third of patients with hemispheric stroke.

Prognosis and complications

A brief sleep history should be part of the diagnostic workup for every stroke or transient ischemic attack and should include the following details:

(1) presence of loud snoring
(2) witnessed apneas
(3) frequent arousals, particularly with gasping
(4) nonrestorative sleep
(5) excessive daytime sleepiness
(6) nocturia (17)

Presence of the above symptoms may alert the clinician to the need for polysomnography, particularly if the patient is overweight or obese, because obstructive sleep apnea increases morbidity and mortality in patients with stroke (76; 98). Sleepiness, fatigue, and poststroke depression are all likely to exert an unfavorable influence on stroke outcomes through effects on motivation and performance (19; 47; 74). All of these conditions are often associated with reduced sleep quality, which may independently impair performance. Furthermore, the lack of restorative sleep generally leads to impaired sleep hygiene, such as excessive napping during the day, further reducing nocturnal sleep efficiency.

Obstructive sleep apnea independently contributes to cognitive dysfunction in patients with stroke through hypoxemia and sleeping discontinuity. The prospective memory test is a simple but sensitive method to detect sleep apnea-induced cognitive impairment in patients with stroke (107).

In the multicenter study Ethnic/Racial Variations of Intracerebral Hemorrhage, which recruited 3000 cases with intracranial hemorrhage and 3000 controls, 2064 (71%) cases and 1516 (52%) controls were classified as having obstructive sleep apnea by the Berlin Questionnaire (36). Cases with obstructive sleep apnea were significantly more likely to be male and have hypertension, heart disease, hyperlipidemia, and higher body mass index compared with those without obstructive sleep apnea. Obstructive sleep apnea was more common among intracerebral cases compared with controls (71% vs. 52%; odds ratio 2.28, 95% CI 2.05-2.55). The authors concluded that obstructive sleep apnea is a risk factor for intracerebral hemorrhage.

In a study of 204 patients with ischemic stroke, nocturnal hypoxemia and central apneas increased mortality, but not recurrent strokes, after ischemic stroke (46).

Obstructive sleep apnea (OSA) has significant effects on cognition impairment in patients with minor ischemic stroke, according to a study conducted in China in 94 patients where 35 had no OSA, 32 had mild OSA, and 27 had moderate-to-severe OSA (108). The authors concluded that hypoxemia may be a potential pathophysiological mechanism of obstructive sleep apnea-induced cognitive impairment.

Clinical vignette

JT was a 62-year-old male who presented with dysphasia and minimal right hemiparesis. He had a history of hypertension, noninsulin-dependent diabetes mellitus, gout, chronic alcoholism, chronic pancreatitis, and depression. He was on multiple cardiovascular medications, glipizide, and fluoxetine. On examination, his blood pressure was 110/70. He was talking incomprehensibly, and his family said that he had become more forgetful. There was a predominantly Wernicke-type dysphasia and a right visual field cut. Chest x-ray revealed moderate congestive heart failure. CT revealed old lacunae in the left hemisphere along with a new hypodensity in the left temporal-occipital area with obliteration of sulci. There were also periventricular ischemic changes. The echocardiogram revealed enlargement of the left atrium and dysfunction of the left ventricle. He was thought to have an embolic stroke and was started on crystalline warfarin sodium and an angiotensin-converting enzyme inhibitor, but these medications were discontinued because of poor tolerance. He was seen in the Sleep-Wake Disorder Unit three months later. In the interim, with the help of speech therapy, his dysphasia markedly improved. He complained of insomnia and fatigue since his stroke and insisted that he had no sleep complaints previously. He denied abnormal leg movements or breathing problems. At the time of the sleep study, he reported that his usual sleeping hours were from 3 A.M. to 6:30 A.M. and that he was not sleepy and unable to fall asleep before that time. The polysomnogram revealed a bedtime of 10:47 P.M. and an arise time of 5:42 A.M. His sleep efficiency was 85%, with a latency to sleep of 24 minutes and 27 minutes to the first REM period. Stage 1 was 34%, delta sleep was completely absent, and REM sleep was 20%. He had 151 respiratory events, of which 47 were apneas and 104 hypopneas. They were predominantly obstructive in nature. The apnea-hypopnea index was 25.6, and the lowest oxygen saturation was 89% in REM sleep. He spent 68% of his sleep time in a supine position; respiratory events were posture-dependent. There were no periodic leg movements. The multiple sleep latency test revealed a latency of 18 minutes, and there were no sleep-onset REM periods.

Comment. This may be an example of a sleep disorder precipitated by stroke, which seems to be much less common than preexisting obstructive sleep apnea acting as a risk factor for stroke. The complaint of insomnia was only partially confirmed by the polysomnogram, but he did have significant apnea. Of note is his lack of obesity (five feet nine inches tall and 135 pounds) and the fact that there was no excessive daytime sleepiness, either subjectively or objectively. Finally, his short REM latency on the polysomnogram was related either to his previous depression (despite fluoxetine), to the presence of brain damage in the left hemisphere, or both factors acting in concert.

Biological basis

Etiology and pathogenesis

Obstructive sleep apnea may act as a risk factor for stroke because of its association with systemic hypertension and other risk factors for stroke, including atrial fibrillation. One study found that the morning surge of blood pressure was the strongest predictor of stroke during an average follow-up period of 41 months in elderly hypertensives (49); obstructive sleep apnea may contribute to that surge, and nifedipine, administered at bedtime, may reduce the surge (43). Additionally, changes in autoregulation of cerebral blood flow in severe obstructive sleep apnea may contribute to the increased morning stroke risk (99).

In 2006, the American Heart Association and American Stroke Association, together with other interested groups, issued a guideline on risk factors for stroke in which a recommendation for obtaining a history regarding symptoms of sleep-disordered breathing and referral to a sleep specialist for appropriate patients was considered Class IIb (usefulness/efficacy is less well established by evidence or opinion), Level C (lowest level of evidence – consensus opinion of experts) (38). An update of the guideline has raised the recommendation to Class I (evidence for or general agreement that the procedure is useful and effective), Level A (data derived from multiple randomized clinical trials) (39). The effectiveness of sleep apnea treatment in preventing the occurrence of stroke is still unknown according to the guideline (Class IIb, Level of Evidence C).

Atrial fibrillation has been linked to severe, uncontrolled sleep apnea. Atrial fibrillation increases the risk of stroke by 5% to 10% per year (95). Clinical data have shown a strong relationship between sleep apnea and atrial fibrillation, and epidemiologic studies suggest that sleep apnea is a risk factor for new-onset atrial fibrillation. A large study evaluated 3542 patients without atrial fibrillation who underwent polysomnography and were followed for an average of five years (34). In patients less than 65 years old, nocturnal oxygen desaturation predicted new-onset atrial fibrillation. Sleep apnea may confer a poorer prognosis for recovery after atrial fibrillation interventions. In a study of 424 patients undergoing ablation, sleep apnea more than doubled the risk of acute intraprocedural failure (86). The effects of sleep apnea therapy on atrial fibrillation outcomes are largely unknown, and prospective randomized controlled trials are necessary to clarify this issue. In one study of 47 women and 111 men with subacute ischemic stroke admitted for neurorehabilitation, mean nocturnal desaturation was significantly associated with atrial fibrillation after adjusting for age, neck circumference, Barthel index, and high-density lipoprotein level (odds ratio = 1.19 [95% confidence interval 1.05-1.35], P = .008) (16). The authors concluded that nocturnal hypoxia due to obstructive sleep apnea is an independent predictor of atrial fibrillation in patients with subacute ischemic stroke. Another study has confirmed the high prevalence of sleep apnea in stroke-affected patients and has identified atrial fibrillation as a major source of stroke in this population, concluding that the strong correlation between age and sleep apnea drives the increased frequency of stroke related to atrial fibrillation (77).

In a study, the authors investigated whether obstructive sleep apnea is independently associated with worse cardiovascular and neurologic outcomes in patients with atrial fibrillation (29). The authors conducted a retrospective cohort study of 22,760 patients with atrial fibrillation with and without obstructive sleep apnea. They found that 4,045 (17.8%) patients had obstructive sleep apnea at baseline. Median follow-up time was 1.5 years; 1895 patients experienced major adverse cardiac events, neurologic events, or both. Patients with obstructive sleep apnea were younger, more likely male, and had increased body mass index. Those with obstructive sleep apnea had a higher prevalence of comorbidities such as diabetes, chronic obstructive pulmonary disease, and heart failure, and higher use of antithrombotic therapy. After adjustments, the presence of obstructive sleep apnea was significantly associated with major adverse cardiac and neurologic events (hazard ratio: 1.16 [95% CI: 1.03-1.31], P = .011). Obstructive sleep apnea was also an independent risk factor for stroke but not cardiovascular death, myocardial infarction, new-onset heart failure, or major bleeding. The authors concluded that among patients with atrial fibrillation, obstructive sleep apnea is an independent risk factor for major adverse cardiac and neurologic events, and more specifically, stroke.

In severe obstructive sleep apnea, oxygen saturation may fall below 85% for more than half the night and may frequently reach levels below 50%. The consequences of this degree of oxygen desaturation include early onset thickening of the carotid artery wall, eve before the appearance of other risk factors, such as hypertension (92). In addition, accelerated carotid atherosclerosis accompanies heavy snoring independent of sleep-disordered breathing (58). Perhaps this is related to the effects of vibration on the carotid artery.

Inflammation and hypoxia are intertwined at the molecular, cellular, and clinical levels. Repeated hypoxia may damage the endothelium and trigger the release of proinflammatory factors like plasma cytokines, tumor necrosis factor-alpha, and interleukin-6 (56). Chronic intermittent hypoxia causes vascular dysfunction by increasing endothelin, augmenting neurovascular oxidative stress, decreasing vascular neuromuscular reserve, reducing vascular reactivity, and increasing susceptibility to injury (13).

Wake-up stroke refers to the presence of symptoms and signs of stroke on awakening. Wake-up stroke conjures the notion of some vascular event occurring during the night while the patient is asleep. Clinically significant sleep apnea, nocturnal hypoxemia, atrial fibrillation secondary to hypoxemia, and right-to-left shunt triggered by apnea events in patients with patent foramen ovale should be considered. In a study of 71 patients with mild to moderate stroke, the authors aimed to determine independent variables associated with wake-up stroke (44). Of the 71 patients, 26 (36.6%) had wake-up stroke. Comparing both groups, patients with wake-up stroke had a significantly higher apnea-hypopnea index (23.1 ± 19.4 vs. 12.5 ± 11.9, p = 0.016) and lower mean blood oxygen saturation (95.1 ± 1.5 vs. 95.8 ± 1.3, p = 0.046) than the patients with non-wake-up stroke. Severe sleep-disordered breathing (apnea-hypopnea index 30 or higher) was the only independent variable associated with wake-up stroke (OR 6.065, 95% CI 1.451-25.350; p = 0.014). The authors concluded that obstructive sleep apnea is an independent risk factor associated with wake-up stroke. In a case-control study conducted on 170 patients with acute stroke, those who woke up with the symptoms were labeled as wake-up stroke, and those whose stroke occurred while awake were labeled as non-wake-up stroke (68). Of 40 patients with wake-up stroke, 72.5% had underlying obstructive sleep apnea based on the Berlin Questionnaire, whereas only 45% of the 67 patients with non-wake-up stroke had underlying obstructive sleep apnea. The authors concluded that obstructive sleep apnea is an important risk factor for ischemic stroke during sleep.

In a study of 335 patients (mean age 64 years) with wake-up stroke or transient ischemic attack, 202 (60%) had at least one long obstructive sleep apnea (greater than 20 seconds) and 116 (35%) a right-to-left shunt; 69 (21%) had both (21). There were significantly more wake-up strokes and transient ischemic attacks in subjects with right-to-left shunt plus long obstructive sleep apnea than those without this association (27/69 vs. 70/266; OR 1.91, 95% CI 1.08 to 3.38; p=0.03). The authors concluded that the combination of long obstructive sleep apnea and right-to-left shunt could be a potentially treatable risk factor for cerebrovascular ischemic events. The authors hypothesized that long obstructive sleep apnea can lead to right-to-left shunting and propitiate paradoxical embolism.

To investigate the relationship between nocturnal atrial fibrillation and wake-up stroke, Riccio and colleagues prospectively assessed every patient with acute ischemic stroke or transient ischemic attack admitted to the hospital over a 3-year period (80). They studied 356 patients, 274 (77.0%) with a diagnosis of acute ischemic stroke and 82 (23.0%) with transient ischemic attack. A total of 41 (11.5%) events occurred during night sleep. Newly diagnosed atrial fibrillation was detected in 27 patients of 272 without known atrial fibrillation (9.9%). The authors found an independent association between newly diagnosed atrial fibrillation and wake-up ischemic stroke and transient ischemic attack (odds ratio 3.6, 95% confidence interval 1.2-7.7, p = 0.019) and concluded that the odds of detecting newly diagnosed atrial fibrillation were 3-fold higher among wake-up cerebrovascular events than among non-wake-up events. In a study of 837 patients with home sleep monitoring, wake-up stroke was not associated with sleep apnea (87).

Severe premorbid obstructive sleep apnea aggravates ischemic stroke, as noted in laboratory experiments by Cananzi and colleagues. The authors developed an air-bag device that enabled them to apply an upper airway obstruction in mice over 3 days, simulating obstructive sleep apnea (12). Cerebral ischemia was induced by performing middle cerebral artery occlusion surgery the day after the completion of rounds of obstructive sleep apnea. The occlusion lasted 60 minutes. The authors found that control mice developed 10.5 ± 5.1% injury, whereas obstructive sleep apnea mice showed a significant increase of 26.2 ± 5.46% infarct. Although the animal model developed by Cananzi and colleagues does not replicate precisely human obstructive sleep apnea, it has sufficient parallelisms to strongly suggest that severe premorbid obstructive sleep apnea significantly aggravates the impact of ischemia on the brain. Prestroke injury to the vascular bed damage may occur through various pathophysiologic mechanisms, including endothelial damage, sympathetic activation, and acute hypertension.

On the other hand, animal models also show that brains exposed to intermittent brief, mild ischemia reveal a measure of protection against ischemic stroke, a phenomenon known as ischemic preconditioning. The neuroprotective effect in ischemic preconditioning is mediated by an attenuation of the mechanisms of injury, along with the activation of defense mechanisms, and enhancement of endogenous repair processes via neuronal and humoral pathways (37). Its presence can be determined either by studying these pathways or by determining the extent of ischemic injury. Investigators have found that neuroglobin, a known neuroprotector, is up-regulated after ischemic preconditioning, hypothesizing a contribution to the neuroprotective effect of ischemic preconditioning (61). Even remote ischemia exerted in a limb may have a neuroprotective effect (73). Questions have been asked about whether mild intermittent hypoxia in obstructive sleep apnea has a neuroprotective effect and where is the dividing line between aggravation of ischemic injury following severe obstructive sleep apnea and neuroprotection induced by ischemia preconditioning (27). Ischemic preconditioning in patients with moderate to severe obstructive sleep apnea and hypoxia may explain Del Brutto’s observation that obstructive sleep apnea is associated with diffuse subcortical brain damage of vascular origin but not with focal lesions (30).

In a case series, 18 consecutive male patients with a median age of 41 (35 to 50) years received care for acute ischemic stroke (97). All of these patients had laboratory-confirmed asymptomatic COVID-19 infection based on a positive SARS-CoV-2 serological test result. The median time from a positive serological test result to acute ischemic stroke was 54.5 (0 to 130) days, and the median National Institutes of Health Stroke Scale score was 5 (1 to 25). Ten patients (56%) presented with a large vessel occlusion. Three patients (17%) had a possible cardiac source of embolus. The authors concluded that the risk for acute ischemic stroke is higher in adults 50 years of age or younger during the convalescent period of a COVID-19 infection without respiratory symptoms. Obstructive sleep apnea is a risk factor for COVID-19 infection, and this mechanism of stroke should be considered in case of infection (62).

Epidemiology

• Sleep apnea is present in 70% of patients with acute stroke.

Most surveys have reported a 75% incidence of obstructive sleep apnea in patients with stroke. In a 10-year follow-up of subjects enrolled in a large, community-based epidemiologic survey, the relative risk for stroke was significantly greater in those individuals who reported excessive daytime sleepiness, a symptom that may be associated with sleep apnea syndrome (32). More importantly, the ongoing multicenter Sleep Heart Health Study found that even mild degrees of sleep-disordered breathing posed a modest but significant risk factor for stroke with an odds ratio of 1.58 (89). Finally, a number of longitudinal studies have shown that obstructive sleep apnea is a risk factor for stroke. Two studies reported that even after adjustment, the presence of sleep apnea was associated with a greater odds ratio (1.97) for stroke and death compared with a control group after an average follow-up interval of 3.3 years (104) and after 10 years (hazard ratio 1.76) (85). The MESA study (Multiethnic Study of Atherosclerosis) reported a higher incidence of cardiovascular events, including stroke, in patients with a diagnosis of obstructive sleep apnea (105).

The association of stroke with sleep apnea may change with time. Parra and colleagues described polysomnographic findings during the first three days after a first-ever stroke and compared them with the findings three months later (75). The apnea-hypopnea index declined from 71.4 to 61.6 at the later time-point, primarily due to a drop in central events (including Cheyne-Strokes respiration), whereas the number of obstructive events remained stable. This suggests that obstructive apneas usually predate an acute stroke, whereas central apneas may arise from the stroke itself.

Stroke may be more prevalent in women with sleep apnea. In one large study, 71,779 female nurses 40 through 65 years of age without previously diagnosed vascular disease were followed for 8 years, and the frequency of snoring was assessed using mailed questionnaires; 398 women suffered a stroke (45). The age-adjusted relative risk of stroke was 1.60 (95% CI 1.21 to 2.12) for occasional snorers and 1.88 (95% CI 1.29 to 2.74) for habitual snorers. After further adjustments, the association between snoring and vascular disease remained positive at 1.33 (95% CI 1.06 to 1.67) for regular snorers. Although the study did not identify patients with sleep apnea, the assumption was made that habitual snoring was a marker of obstructive sleep apnea and likely the background risk factor for vascular disease.

In another study, the authors provided evidence that stroke has a higher incidence in Chinese women 35 years old or younger, with a sleep apnea/hypopnea index of 5/hour or higher (15). The authors used a universal insurance claims database and identified a large cohort of patients with sleep apnea using polysomnography. They identified 29,961 patients with sleep apnea and compared the sex- and age-specific stroke risk with a control group. The sleep apnea cohort had a higher stroke incidence in women with an adjusted hazard ratio between males and females of 1.21 (95% CI 1.01 to 1.24; p < 0.05) and 1.44 (95% CI 1.20 to 1.72; p < 0.05), respectively. Stratified by age, the effects of sleep apnea on stroke risk in women decreased with advancing age (adjusted HR 4.90, 95% CI 1.93 to 12.4 for subgroup aged 20 to 35 years; adjusted HR 1.64, 95% CI 1.01 to 2.65 for subgroup aged 36 to 50 years; adjusted HR 1.38, 95% CI 1.01 to 1.89 for subgroup aged 51 to 65 years). The authors concluded that young Chinese women with sleep apnea are at higher risk of stroke and hypothesized that structural and hormonal differences in young women might have increased the risk of stroke.

In a study of 394 old males aged 70 to 100 years, the authors concluded that severe obstructive sleep apnea/hypopnea (AHI [apnea/hypopnea index]=30/hour or higher) increases the risk of ischemic stroke in an elderly male non-institutionalized population, independently of known confounding factors (71).

In a cross-sectional analysis of 1475 individuals, the authors found that subjects with an apnea-hypopnea index of 20/hour or greater had increased odds for stroke (odds ratio 4.33; 95% CI 1.32 to 14.24; p = 0.02) compared with those without sleep-disordered breathing (AHI < 5) after adjustment for known confounding factors (02). They concluded that there is a strong association between moderate to severe sleep-disordered breathing and prevalent stroke, independent of confounding factors.

In a large population-based study, among 842 subjects (median age 65 years), the median respiratory event index (REI) score was 14, and 63% had sleep-disordered breathing (09). REI was associated with recurrent ischemic stroke (hazard ratio 1.02; 95% CI 1.01-1.03) but not with mortality alone (hazard ratio 1.00; [95% CI 0.99-1.02). The authors concluded that sleep-disordered breathing may represent an important modifiable risk factor for poor stroke outcomes.

There is growing evidence that small vessel disease and leukoaraiosis are worse in subjects with sleep apnea disorder. White matter disease in the form of leukoaraiosis is associated with sleep-disordered breathing in patients with acute stroke (42), and there is a greater risk of silent strokes in high-risk individuals who have nocturnal oxygen desaturation (31). A study found that obstructive sleep apnea with an AHI of more than 15/hour is a risk factor for cerebral white matter changes in middle-aged and older patients (OR 2.08; 95% CI 1.05 to 4.13) (51). Also, it has been shown that obstructive sleep apnea with an AHI of more than 15 is a risk factor for silent cerebral infarction in patients older than 65 (OR 2.44; 95% CI1.03 to 5.80) (20). In another study, moderate-to-severe obstructive sleep apnea was associated with multiple indicators of cerebral small vessel disease, including white matter hyperintensities, cerebral microbleeds, and enhanced perivascular spaces, as seen in MRI (94). It has also been suggested that moderate-to-severe obstructive sleep apnea can be one of the independent predictors of cerebral microbleeds, which are considered a surrogate marker of overt stroke (52). White matter hyperintensities represent a combination of microinfarcts, gliosis, and edema.

Periventricular leukoaraiosis

MRI of head (FLAIR T2) showing white matter hyperintensities (leukoaraiosis) in 87-year-old man with sleep apnea, cognitive deficit, gait disturbance, and urinary incontinence typical of Binswanger disease. (Contributed by Antonio...

In a study of dynamic susceptibility with contrast and dynamic contrast-enhanced MRI in 27 patients to determine cerebral blood flow and blood-brain barrier permeability, expressed as leakage rate and volume, the authors found a decrease in cerebral blood flow and an increase in leakage in the perilesional zones close to white matter hyperintensities (106; 102). The authors concluded that blood-brain barrier impairment and hypoperfusion in relation to white matter hyperintensities suggest deterioration of a physiologic regulatory mechanism.

The extensive white matter lesions partially disconnect the thalamus and other basal ganglia from preferentially frontal cortical regions. In fact, the frontal cortex in patients with obstructive sleep apnea suffering hypoxia may be abnormally thin (63). A thin cortex might be the consequence of transneuronal degeneration as a result of disconnection at the periventricular white matter level, although direct cortical damage by hypoxia cannot be ruled out. Obstructive sleep apnea may be a risk factor for subcortical ischemic vascular dementia, or Binswanger disease, a form of vascular dementia in the elderly (82). Binswanger disease is manifested by executive dysfunction, gait disorder, and urinary incontinence. Individuals with moderate-to-severe obstructive sleep apnea are almost four times more likely to have diffuse subcortical damage of vascular origin than those with none-to-mild obstructive sleep apnea, independently of demographics and cardiovascular risk factors (30). White matter hyperintensity progression has been associated with lower extremity dysfunction during aging and verbal memory deficits (69; 96). Executive dysfunction and slow-gait speed progression have been associated with sleep apnea, and there is some evidence that CPAP treatment improves gait control in severe obstructive sleep apnea (79; 57; 03).

These observations support the hypothesis that brain regions with poor hemodynamic reserve are preferentially affected in sleep apnea and coincide with reports of permanent alteration of auditory event-related potentials in these patients. In fact, obstructive sleep apnea may be a risk factor for subcortical ischemic vascular dementia (28), a notion supported by the observation that older women (mean age 82.3 years) with obstructive sleep apnea more than 15/hour were more likely to develop mild cognitive impairment or dementia (adjusted odds ratio [AOR] 1.85; 95% CI 1.11 to 3.08) (103; 83). In a home polygraphic study of 2636 men (median age 76.0 ± 5.3 years), it was found that nocturnal hypoxemia was associated with cognitive mental decline as measured by the Modified Mini-Mental (MMM) scores (04). For every five points of increment in the desaturation index, there was an annualized decline in MMM of 0.36 points (P=0.01. In a study of patients with minimal cognitive impairment or with Alzheimer disease, the results showed that in patients with sleep apnea, mental decline started at an earlier age (MC, group 1: 72.63 vs. 83.67; MC, group 2: 72.15 vs. 83.45; MC, group 3: 77.40 vs. 89.89; p < 0.01) (AC, group 3: 83.46 vs. 88.13; p < 0.05) (72). These studies further suggest that early therapeutic intervention in sleep apnea is desirable.

Prevention

	• Treatment of sleep apnea may lower the incidence of vascular morbidity and mortality.
	• Vascular dementia may be modifiable with appropriate treatment of obstructive sleep apnea.

The treatment of patients with severe obstructive sleep apnea with CPAP during an average 10.1-year period reduced fatal and nonfatal events, including stroke, compared with untreated patients with sleep apnea (64). Another study demonstrated the efficacy of CPAP treatment for the prevention of vascular events (ie, myocardial infarction, stroke, acute coronary syndrome, and vascular death) in patients with mild to moderate obstructive sleep apnea (AHI 30.9 +/- 21.8) versus untreated controls (AHI 15.3+/-13.0). Over a 6-year follow-up period, treated patients had a 28.5% risk reduction compared with the control group, independent of other possible confounding risk factors (10). Another small study found that administration of auto-titrating CPAP to patients with transient ischemic attack and obstructive sleep apnea nonsignificantly reduced the incidence of vascular events during a 90-day period following the transient ischemic attack compared with a non-treated control group (2% [one of 45 patients] vs. 12% [three of 25]) (05). Timely diagnosis and treatment of obstructive sleep apnea may also alleviate the worsened functional outcome of patients with stroke who have sleep apnea (19; 47; 84). Another important modifiable risk factor may be insufficient or excessive sleep. The relative risk for ischemic stroke in postmenopausal women followed for 7.5 years was 1.22 in those women who reported sleeping less than or equal to six hours per night and who had no cardiovascular disease at baseline (18). In the same group of women, longer sleep (more than or equal to nine hours per night) was also an independent risk factor for stroke. Similar findings in the general population were reported by Grandner and colleagues (40). Analysis of data from the very large Nurses’ Health Study has also revealed a slightly enhanced stroke risk (hazard ratio 1.04) from cumulative lifetime rotating night shifts, suggesting circadian rhythm disruption along with sleep deprivation as causative factors (08). Finally, a meta-analysis has confirmed the deleterious effect of short sleep on ischemic stroke incidence in 15 studies comprising 474,684 individuals (relative risk 1.15); in this meta-analysis, long sleep was also significant (RR 1.65) (14).

In a study of Medicare beneficiaries, 5757 met inclusion criteria as follows: aged 65 years or older, newly diagnosed with obstructive sleep apnea, had initiated CPAP therapy, and were followed over 25 months (101). Of these, 407 (7%) patients experienced stroke. CPAP adherence was associated with a reduced risk of stroke (hazard ratio 0.98; 95% confidence interval 0.96, 0.99) over 25 months, indicating a 2% reduction in the risk of stroke for each month of CPAP adherence. Stratification showed that the protective effect remained significant for the 12- and 6-month outcome models but not the 3-month outcome model. The authors concluded that CPAP adherence was associated with a significantly reduced risk of stroke.

Management

• Effective management of vascular risk factors and of sleep apnea delays neurocognitive decline in patients with moderate to severe sleep apnea.

Obstructive sleep apnea adversely affects the length of hospitalization and functional capacity after ischemic strokes (19; 47). In patients with acute stroke, altered vasomotor reactivity may be aggravated by sleep apnea (01). The authors reported the occurrence of intracranial blood flow steal in response to changing vasodilatory stimuli like carbon dioxide elevations in patients with sleep apnea and stroke. This phenomenon has been termed the “reversed Robin Hood syndrome.” It might play a pivotal role in clinical deterioration after an acute stroke and has led to the notion that noninvasive ventilatory correction in select patients with acute stroke might have a beneficial effect on sleep apnea and brain perfusion.

The efficacy of positive airway pressure therapy in stroke outcomes remains controversial. Continuous positive airway pressure reduced the incidence of recurrent strokes during a 5-year follow-up period in patients with sleep apnea compared with patients who did not tolerate the treatment (66). One study reported a reduction of deaths from cardiovascular events (cardiac and cerebrovascular) in patients with severe sleep apnea treated with CPAP over an average period of 10.1 years (64), and another study described a 28.5% reduction in vascular morbidity and mortality even in cases of less severe obstructive sleep apnea (apnea-hypopnea index 30.9 +/- 21.8) compared with nontreated patients (average follow-up six years) (10).

One study showed that therapy with CPAP plus usual care, as compared with usual care alone, did not prevent cardiovascular events in patients with moderate-to-severe obstructive sleep apnea and established cardiovascular disease (67). However, the study results were clinically uncertain because patients received an average of 3.7 hours of CPAP applications per night, which is considered to be a subtherapeutic duration of therapy. Another study evaluated the efficacy of CPAP therapy for stroke prevention in patients with obstructive sleep apnea (55). In a systematic review of randomized controlled trials, two independent reviewers explored different databases and evaluated the risk of bias. Subgroup analysis and meta-regression revealed no effect on proposed outcomes. The authors concluded that although there was no evidence that CPAP therapy improves stroke outcomes, concerns regarding the risk of bias, CPAP adherence, and the population included in each clinical trial might have reduced the strength of the findings to support the benefit in all patients. The authors finalized by stating that future research exploring these relevant outcomes is needed.

In another study, 679 patients with stroke were screened to assess the effect of CPAP treatment on the prevention of new vascular events among patients with stroke and obstructive sleep apnea (41). On follow-up at 3, 6, and 12 months from randomization, significantly better stroke outcomes were found. Recurrence of vascular events showed nonsignificant favorable outcomes, likely because the follow-up time was insufficient. In a systematic review and meta-analysis of 10 randomized controlled trials examining the effectiveness of CPAP in stroke patients with sleep-disordered breathing, the results showed an overall neurofunctional improvement with CPAP (SMD 0.5406, 95% CI 0.0263-1.0548) in the combined analysis of NIH Stroke Scale and Canadian Neurological Scale (07). The overall data indicated that CPAP might be beneficial for neurologic recovery and should be considered in patients with clinically significant sleep apnea who tolerate PAP devices.

Patients with cerebrovascular disease and hypertension have a high prevalence of obstructive sleep apnea. The use of portable polysomnography and autotitrating CPAP in the patients' homes improved both the diagnosis and the treatment for sleep apnea compared with usual care but did not lower blood pressure (06). In a study of 126 subjects screened for arterial hypertension and obstructive sleep apnea, repeated cognitive measurements were performed (53). The authors concluded that arterial hypertension and obstructive sleep apnea appear to be risk factors in common neurocognitive disorders, and cognitive decline may be mitigated by treating these risk factors.

Results in the study by Osorio and colleagues showed that treatment with CPAP slowed the onset and progression of mental decline (CMC, group 1: 72.63 vs. 82.10; CMC group 2: 72.11 vs. 82.10; p < 0.01) (72). In a subsequent study, a different group of authors investigated the impact of CPAP use on cognition in patients with obstructive sleep apnea and cognitive impairment due to neurodegenerative or vascular disease (22). Duration of CPAP therapy and good CPAP adherence for a duration of 2 to 12 months was associated with a 2.3-point higher follow-up MoCA score (p < 0.001) and a 1.2-point higher follow-up MMSE score (p = 0.01). The authors concluded that the use of CPAP therapy is associated with improved cognitive outcomes in patients with obstructive sleep apnea and cognitive impairment due to a neurodegenerative or vascular etiology.

For patients who do not tolerate continuous positive airway pressure, alternative therapies include various modes of surgery or dental devices. Weight reduction for obese patients and alcoholism treatment should be encouraged. Besides CPAP, intravenous theophylline and oxygen inhalation are the most effective therapies available for stroke patients with periodic breathing.

Subcortical lesions can induce periodic leg movements of sleep (59). If periodic leg movements of sleep are a significant problem, ropinirole .25 to .75 mg or pramipexole up to 0.75 mg before sleep is recommended.

Comprehensive swallowing intervention had therapeutic effects on obstructive sleep apnea and dysphagia after stroke, a mechanism that the authors related to enhancing oropharyngeal muscle strength and changing upper airway structure (78).

References

01: Alexandrov AV, Nguyen HT, Rubiera M, et al. Prevalence and risk factors associated with reversed Robin Hood syndrome in acute ischemic stroke. Stroke 2009;40(8):2738-42. PMID 19461025
02: Arzt M, Young T, Finn L, Skatrud JB, Bradley TD. Association of sleep-disordered breathing and the occurrence of stroke. Am J Respir Crit Care Med 2005;172(11):1447-51. PMID 16141444
03: Baillieul S, Wuyam B, Pépin JL, et al. Continuous positive airway pressure improves gait control in severe obstructive sleep apnoea: A prospective study. PLoS One 2018;13(2):e0192442. PMID 29474363
04: Blackwell T, Yaffe K, Laffan A, et al. Associations between sleep-disordered breathing, nocturnal hypoxemia, and subsequent cognitive decline in older community-dwelling men: the Osteoporotic Fractures in Men Sleep Study. J Am Geriatr Soc 2015;63(3):453-61. PMID 25803785
05: Bravata DM, Concato J, Fried T, et al. Auto-titrating continuous positive airway pressure for patients with acute transient ischemic attack: a randomized feasibility trial. Stroke 2010;41:1464-70. PMID 20508184
06: Bravata DM, McClain V, Austin C, et al. Diagnosing and managing sleep apnea in patients with chronic cerebrovascular disease: a randomized trial of a home-based strategy. Sleep Breath 2017;21(3):713-25. PMID 28386781
07: Brill AK, Horvath T, Seiler A, et al. CPAP as treatment of sleep apnea after stroke: A meta-analysis of randomized trials. Neurology 2018;90(14):e1222-30. PMID 29523641
08: Brown DL, Feskanich D, Sánchez BN, Rexrode KM, Schernhammer ES, Lisabeth LD. Rotating night shift work and the risk of ischemic stroke. Am J Epidemiol 2009;169:1370-7. PMID 19357324
09: Brown DL, Shafie-Khorassani F, Kim S, et al. Sleep-disordered breathing is associated with recurrent ischemic stroke. Stroke 2019;50(3):571-6. PMID 30744545
10: Buchner NJ, Sanner BM, Borgel J, Rump LC. Continuous positive airway pressure treatment of mild to moderate obstructive sleep apnea reduces cardiovascular risk. Am J Respir Crit Care Med 2007;176:1274-80. PMID 17673692
11: Burwell CS, Robin ED, Whaley RD, Bickelmann AG. Extreme obesity associated with alveolar hypoventilation: a Pickwickian syndrome. Am J Med 1956;21:811-8. PMID 13362309
12: Cananzi SG, White LA, Barzega M, et al. Obstructive sleep apnea intensifies stroke severity following middle cerebral artery occlusion. Sleep Med 2020;67:278-85. PMID 32057628
13: Capone C, Faraco G, Coleman C, et al. Endothelin 1-dependent neurovascular dysfunction in chronic intermittent hypoxia. Hypertension 2012;60(1):106-13. PMID 22689747
14: Cappuccio FP, Cooper D, D’Elia L, Strazzullo P, Miller MA. Sleep duration predicts cardiovascular outcomes: a systematic review and meta-analysis of prospective studies. Eur Heart J 2011;32:1484-92. PMID 21300732
15: Chang CC, Chuang HC, Lin CL, et al. High incidence of stroke in young females with sleep apnea syndrome. Sleep Med 2014;15(4):410-4. PMID 24684976
16: Chen CY, Ho CH, Chen CL, Yu CC. Nocturnal desaturation is associated with atrial fibrillation in patients with ischemic stroke and obstructive sleep apnea. J Clin Sleep Med 2017;13(5):729-35. PMID 28356180
17: Chen CY, Hsu CC, Pei YC, Yu CC, Chen YS, Chen CL. Nocturia is an independent predictor of severe obstructive sleep apnea in patients with ischemic stroke. J Neurol 2011;258:189-94. PMID 20725736
18: Chen JC, Brunner RL, Ren H, et al. Sleep duration and risk of ischemic stroke in postmenopausal women. Stroke 2008;39(12):3185-92. PMID 18635832
19: Cherkassky T, Oksenberg A, Froom P, Ring H. Sleep-related breathing disorders and rehabilitation outcome of stroke patients: a prospective study. Am J Phys Med Rehabil 2003;82(6):452-5. PMID 12820788
20: Cho ER, Kim H, Seo HS, Suh S, Lee SK, Shin C. Obstructive sleep apnea as a risk factor for silent cerebral infarction. J Sleep Res 2013;22(4):452-8. PMID 23374054
21: Ciccone A, Proserpio P, Roccatagliata DV, et al; DARIA (Detection of Sleep Apnea as Risk Factor in Acute Stroke) Investigators. Wake-up stroke and TIA due to paradoxical embolism during long obstructive sleep apnoeas: a cross-sectional study. Thorax 2013;68:97-104. PMID 23076389
22: Costa YS, Lim ASP, Thorpe KE, et al. Investigating changes in cognition associated with the use of CPAP in cognitive impairment and dementia: a retrospective study. Sleep Med 2023;101:437-44. PMID 36516600
23: Culebras A. Central sleep apnea may be central to acute stroke. Sleep Med 2021;77:302-3. PMID 33127306
24: Culebras A. Sleep apnea and stroke. Curr Neurol Neurosci Rep 2015;15(1):503. PMID 25407131
25: Culebras A. Sleep, stroke and poststroke. Neurologic Clinics 2012;(30)4:1275-84.** PMID 23099137
26: Culebras A, editor. Sleep, stroke and cardiovascular disease. Cambridge University Press, 2013.
27: Culebras A. Exploring the trail between cerebral ischemic aggravation and ischemic preconditioning. Obstructive sleep apnea leads the way. Sleep Med 2020;67:276-7. PMID 32094093
28: Culebras A, Anwar S. Sleep apnea is a risk factor for stroke and vascular dementia. Curr Neurol Neurosci Rep 2018;18(8):53. PMID 29938308
29: Dalgaard F, North R, Pieper K, et al. Risk of major cardiovascular and neurologic events with obstructive sleep apnea among patients with atrial fibrillation. Am Heart J 2020;223:65-71. PMID 32179257
30: Del Brutto OH, Mera RM, Zambrano M, Castillo PR. Relationship between obstructive sleep apnea and neuroimaging signatures of cerebral small vessel disease in community-dwelling older adults. The Atahualpa Project. Sleep Med 2017;37:10-12. PMID 28899518
31: Eguchi K, Kario K, Hoshida S, Ishikawa J, Morinari M, Shimada K. Nocturnal hypoxia is associated with silent cerebrovascular disease in a high-risk Japanese community-dwelling population. Am J Hypertens 2005;18:1489-95. PMID 16280287
32: Empana JP, Dauvilliers Y, Dartigues JF, et al. Excessive daytime sleepiness is an independent risk indicator for cardiovascular mortality in community-dwelling elderly: the three city study. Stroke 2009;90:1219-24. PMID 19246707
33: Estai M, Walsh J, Maddison K, et al. Sleep-disordered breathing in patients with stroke-induced dysphagia. J Sleep Res 2021;30(3):e13179. PMID 32856372
34: Gami AS, Hodge DO, Herges RM, et al. Obstructive sleep apnea, obesity, and the risk of incident atrial fibrillation. J Am Coll Cardiol 2007;49(5):565-71. PMID 17276180
35: Gastaut H, Tassinari CA, Duron B. Polygraphic study of the episodic diurnal and nocturnal (hypnic and respiratory) manifestations of the Pickwick syndrome. Brain Res 1966;2:167-86. PMID 5923125
36: Geer JH, Falcone GJ, Vanent KN, et al. Obstructive sleep apnea as a risk factor for intracerebral hemorrhage. Stroke 2021;52(5):1835-8. PMID 33827242
37: Gidday JM. Cerebral preconditioning and ischaemic tolerance. Nat Rev Neurosci 2006;7(6):437-48. PMID 16715053
38: Goldstein LB, Adams R, Alberts MJ, et al. Primary prevention of ischemic stroke: a guideline from the American Heart Association/American Stroke Association Stroke Council: cosponsored by the Atherosclerotic Peripheral Vascular Disease Interdisciplinary Working Group; Cardiovascular Nursing Council; Clinical Cardiology Council; Nutrition, Physical Activity, and Metabolism Council; and the Quality of Care and Outcomes Research Interdisciplinary Working Group. Circulation 2006;113(24):e873-923. PMID 16785347
39: Goldstein LB, Bushnell CD, Adams RJ, et al. Guidelines for the primary prevention of stroke: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke 2011;42:1-68. PMID 21127304
40: Grandner MA, Jackson NJ, Pak VM, Gerhrman PR. Sleep disturbance is associated with cardiovascular and metabolic disorders. J Sleep Res 2012;21(4):427-33. PMID 22151079
41: Gupta A, Shukla G, Afsar M, Poornima S, Pandey RM, Goyal V, et al. Role of positive airway pressure therapy for obstructive sleep apnea in patients with stroke: a randomized controlled trial. J Clin Sleep Med 2018;14:511–21. PMID 29609704
42: Harbison J, Gibson GJ, Birchall D, Zammit-Maempel I, Ford GA. White matter disease and sleep-disordered breathing after acute stroke. Neurology 2003;61(7):959-63. PMID 14557568
43: Hermida RC, Ayala DE, Mojón A, Alonso I, Fernandez JR. Reduction of morning blood pressure surge after treatment with nifedipine GITS at bedtime, but not upon awakening, in essential hypertension. Blood Pressure Monit 2009;14:152-9. PMID 19543080
44: Hsieh SW, Lai CL, Liu CK, Hsieh CF, Hsu CY. Obstructive sleep apnea linked to wake-up strokes. J Neurol 2012;259:1433-9. PMID 22215237
45: Hu FB, Willett WC, Manson JE, et al. Snoring and risk of cardiovascular disease in women. J Am Coll Cardiol 2000;35(2):308-13. PMID 10676674
46: Huhtakangas JK, Saaresranta T, Vähänikkilä H, Huhtakangas J. Nocturnal hypoxemia and central apneas increase mortality, but not recurrent ischemic events after ischemic stroke. Sleep Med 2022;97:1-9. PMID 35679775
47: Kaneko Y, Hajek VE, Zivanovic V, Raboud J, Bradley TD. Relationship of sleep apnea to functional capacity and length of hospitalization following stroke. Sleep 2003;26(3):293-7. PMID 12749548
48: Kapen S, Goldberg J, Wynter J, Diskin C. The incidence of obstructive sleep apnea in ischemic stroke patients. Sleep Res 1991;20:379.
49: Kario K, Ishikawa J, Pickering TG, et al. Morning hypertension: the strongest independent risk factor for stroke in elderly hypertensive patients. Hypertens Res 2006;29(8):581-7. PMID 17137213
50: Kario K, Pickering TG, Matsuo T, Hoshide S, Schwartz JE, Shimada K. Stroke prognosis and abnormal nocturnal blood pressure falls in older hypertensives. Hypertension 2001;38:852-7. PMID 11641298
51: Kim H, Yun CH, Thomas RJ, et al. Obstructive sleep apnea as a risk factor for cerebral white matter change in a middle-aged and older general population. Sleep 2013;36(5):709-15B. PMID 23633753
52: Koo DL, Kim JY, Lim JS, Kwon HM, Nam H. Cerebral microbleeds on MRI in patients with obstructive sleep apnea. J Clin Sleep Med 2017;13(1):65-72. PMID 27655453
53: Kujovic M, Lipka T, Zalman M, Baumann L, Jänner M, Baumann B. Treatment of hypertension and obstructive sleep apnea counteracts cognitive decline in common neurocognitive disorders in diagnosis-related patterns. Sci Rep 2023;13(1):7556. PMID 37160982
54: Kukla C, Sander D, Schwarze J, Wittich I, Klingelhofer J. Changes of circadian blood pressure patterns are associated with the occurrence of lacunar infarction. Arch Neurol 1998;55:683-8. PMID 9605725
55: Labarca G, Dreyse J, Drake L, Jorquera J, Barbe F. Efficacy of continuous positive airway pressure (CPAP) in the prevention of cardiovascular events in patients with obstructive sleep apnea: systematic review and meta-analysis. Sleep Med Rev 2020;52:101312. PMID 32248026
56: Lavie L. Sleep apnea syndrome, endothelial dysfunction, and cardiovascular morbidity. Sleep 2004;27(6):1053-5. PMID 15532197
57: Lee S, Shin C. Interaction of obstructive sleep apnoea and cognitive impairment with slow gait speed in middle-aged and older adults. Age Ageing 2017;46(4):653-9. PMID 28057621
58: Lee SA, Amis TC, Byth K, et al. Heavy snoring as a cause of carotid artery atherosclerosis. Sleep 2008;31(9):1207-13. PMID 18788645
59: Lee SJ, Kim JS, Song IU, An JY, Kim YI, Lee KS. Poststroke restless legs syndrome and lesion location: anatomical considerations. Mov Disord 2009;24(1):77-84. PMID 18816657
60: Lindner A, Fornadi K, Lazar AS, et al. Periodic limb movements in sleep are associated with stroke and cardiovascular risk factors in patients with renal failure. J Sleep Res 2012;21(3):297-307. PMID 21917047
61: Liu Y, Li B, Li Q, Zou L. Neuroglobin up-regulation after ischaemic pre-conditioning in a rat model of middle cerebral artery occlusion. Brain Inj 2015;29(5):651-7. PMID 25625519
62: Maas MB, Kim M, Malkani RG, Abbott SM, Zee PC. Obstructive sleep apnea and risk of COVID-19 infection, hospitalization and respiratory failure. Sleep Breath 2021;25(2):1155-7. PMID 32989673
63: Macey PM, Haris N, Kumar R, Thomas MA, Woo MA, Harper RM. Obstructive sleep apnea and cortical thickness in females and males. PLoS ONE 2018;13(3):e0193854. PMID 29509806
64: Marín JM, Carrizo SJ, Vicente E, Agustí AG. Long-term cardiovascular outcomes in men with obstructive sleep apnoea-hypopnoea with or without treatment with continuous positive airway pressure: an observational study. Lancet 2005;365:1046-53. PMID 15781100
65: Marshall J. Diurnal variation in occurrence of strokes. Stroke 1977;8:230-1. PMID 557853
66: Martínez-García MA, Soler-Cataluña JJ, Ejarque-Martínez L, et al. Continuous positive airway pressure treatment reduces mortality in patients with ischemic stroke and obstructive sleep apnea: a 5-year follow-up study. Am J Respir Crit Care Med 2009;180:36-41. PMID 19406983
67: McEvoy RD, Antic NA, Heeley E, et al. CPAP for prevention of cardiovascular events in obstructive sleep apnea. N Engl J Med 2016;375(10):919-31. PMID 27571048
68: Mohammad Y, Almutlaq A, Al-Ruwaita A, Aldrees A, Alsubaie A, Al-Hussain F. Stroke during sleep and obstructive sleep apnea: there is a link. Neurol Sci 2019;40(5):1001-5. PMID 30758735
69: Moon SY, de Souto Barreto P, Rolland Y, et al. Prospective associations between white matter hyperintensities and lower extremity function. Neurology 2018;90(15):e1291-7. PMID 29523640
70: Muñoz R, Durán-Cantolla J, Martínez-Vila E, et al. Central sleep apnea is associated with increased risk of ischemic stroke in the elderly. Acta Neurol Scand 2012;126(3):183-8. PMID 22150745
71: Muñoz R, Durán-Cantolla J, Martínez-Vila E, et al. Severe sleep apnea and risk of ischemic stroke in the elderly. Stroke 2006;37(9):2317-21. PMID 16888274
72: Osorio RS, Gumb T, Pirraglia E, et al. Sleep-disordered breathing advances cognitive decline in the elderly. Neurology 2015;84(19):1964-71. PMID 25878183
73: Pan J, Li X, Peng Y. Remote ischemic conditioning for acute ischemic stroke: dawn in the darkness. Rev Neurosci 2016;27:501-10. PMID 26812782
74: Park JY, Chen MH, Kang SH, Lee A, Kim BR, Shin MJ. Functional outcome in poststroke patients with or without fatigue. Am J Phys Med Rehabil 2009;88:554-8. PMID 19325456
75: Parra O, Arboix A, Bechich S, et al. Time course of sleep-related breathing disorders in first-ever stroke or transient ischemic attack. Am J Respir Crit Care Med 2000;161:375-80. PMID 10673174
76: Parra O, Arboix A, Montserrat JM, Quinto L, Bechich S, García-Eroles L. Sleep-related breathing disorders: impact on mortality of cerebrovascular disease. Eur Respir J 2004;24:267-72. PMID 15332396
77: Poli M, Philip P, Taillard J, et al. Atrial fibrillation is a major cause of stroke in apneic patients: a prospective study. Sleep Med 2017;30:251-4. PMID 28041720
78: Qian S, Zhang X, Wang T, et al. Effects of comprehensive swallowing intervention on obstructive sleep apnea and dysphagia after stroke: a randomized controlled trial. J Stroke Cerebrovasc Dis 2022;31(8):106521. PMID 35636225
79: Ramos AR, Gardener H, Rundek T, et al. Sleep disturbances and cognitive decline in the Northern Manhattan Study. Neurology 2016;87(14):1511-6. PMID 29523640
80: Riccio PM, Klein FR, Pagani Cassará F, Muñoz Giacomelli F, González Toledo ME, Racosta JM, et al. Newly diagnosed atrial fibrillation linked to wake-up stroke and TIA: hypothetical implications. Neurology 2013;80:1834-40. PMID 23596075
81: Robbins J, Redline S, Ervin A. Walsleben JA, Ding J, Nieto FJ. Associations of sleep-disordered breathing and cerebral changes on MRI. J Clin Sleep Med 2005;1:159-65. PMID 17561631
82: Román GC. Senile dementia of the Binswanger type. A vascular form of dementia in the elderly. JAMA 1987;258(13):1782-8. PMID 3625988
83: Román GC. In: Culebras A, editor. Sleep, stroke and cardiovascular disease. Cambridge University Press, 2013.
84: Ryan CM, Bayley M, Green R, Murray BJ, Bradley TD. Influence of continuous positive airway pressure on outcomes of rehabilitation in stroke patients with obstructive sleep apnea. Stroke 2011;42:1062-7. PMID 21372306
85: Sahlin C, Sandberg O, Gustafson Y, et al. Obstructive sleep apnea is a risk factor for death in patients with stroke: a 10-year follow-up. Arch Intern Med 2008;168(3):297-301. PMID 18268171
86: Sauer WH, McKernan ML, Lin D, Gerstenfeld EP, Callans DJ, Marchlinski FE. Clinical predictors and outcomes associated with acute return of pulmonary vein conduction during pulmonary vein isolation for treatment of atrial fibrillation. Heart Rhythm 2006;3(9):1024-8. PMID 16945795
87: Schutz SG, Lisabeth LD, Gibbs R, et al. Wake-up stroke is not associated with obstructive sleep apnea. Sleep Med 2021a;81:158-62. PMID 33684605
88: Schutz SG, Lisabeth LD, Hsu CW, Kim S, Chervin RD, Brown DL. Central sleep apnea is uncommon after stroke. Sleep Med 2021b;77:304-6. PMID 32948418
89: Shahar E, Whitney CW, Redline S, et al. Sleep-disordered breathing and cardiovascular disease: cross-sectional results of the Sleep Heart Health Study. Am J Respir Crit Care Med 2001;163(1):19-25. PMID 11208620
90: Sharma S, Culebras A. Sleep apnoea and stroke. Stroke Vasc Neurol 2016;1(4):185-91. PMID 28959482
91: Siccoli MM, Valko PO, Hermann DM, Bassetti CL. Central periodic breathing during sleep in 74 patients with acute ischemic stroke – Neurogenic and cardiogenic factors. J Neurol 2008;255(11):1687-92. PMID 19009334
92: Silvestrini M, Rizzato B, Placidi F, Baruffaldi R, Bianconi A, Diomedi M. Carotid artery wall thickness in patients with obstructive sleep apnea syndrome. Stroke 2002;33:1782-5. PMID 12105352
93: Somers VK, White DP, Amin R, et al. Sleep apnea and cardiovascular disease: an American Heart Association/American College of Cardiology Foundation Scientific Statement from the American Heart Association Council for High Blood Pressure Research Professional Education Committee, Council on Clinical Cardiology, Stroke Council, and Council On Cardiovascular Nursing. In collaboration with the National Heart, Lung, and Blood Institute National Center on Sleep Disorders Research (National Institutes of Health). Circulation 2008;118(10):1080-111. PMID 18725495
94: Song TJ, Park JH, Choi KH, et al. Moderate-to-severe obstructive sleep apnea is associated with cerebral small vessel disease. Sleep Med 2017;30:36-42. PMID 28215260
95: Stroke Risk in Atrial Fibrillation Working Group. Independent predictors of stroke in patients with atrial fibrillation: a systematic review. Neurology 2007;69(6):546-54. PMID 17679673
96: Swardfager W, Cogo-Moreira H, Masellis M, et al. The effect of white matter hyperintensities on verbal memory: Mediation by temporal lobe atrophy. Neurology 2018;90(8):e673-82. PMID 29374101
97: Tu TM, Seet CYH, Koh JS, et al. Acute ischemic stroke during the convalescent phase of asymptomatic COVID-2019 infection in men. JAMA Netw Open 2021;4(4):e217498. PMID 33885771
98: Turkington PM, Allgar V, Bamford J, Wanklyn P, Elliott MW. Effect of upper airway obstruction in acute stroke on functional outcome at 6 months. Thorax 2004;59:367-71. PMID 15115859
99: Urbano F, Roux F, Schindler J, Mohsenin V. Impaired cerebral autoregulation in obstructive sleep apnea. J Appl Physiol 2008;105(6):1852-7. PMID 18927265
100: Vock J, Achermann P, Bischof M, et al. Evolution of sleep and sleep EEG after hemispheric stroke. J Sleep Res 2002;11(4):331-8. PMID 12464101
101: Wickwire EM, Bailey MD, Somers VK, et al. CPAP adherence is associated with reduced risk for stroke among older adult Medicare beneficiaries with obstructive sleep apnea. J Clin Sleep Med 2021;17(6):1249-55. PMID 33612161
102: Wong SM, Jansen JFA, Zhang CE, et al. Blood-brain barrier impairment and hypoperfusion are linked in cerebral small vessel disease. Neurology 2019;92(15):e1669-77. PMID 30867275
103: Yaffe K, Laffan AM, Harrison SL, et al. Sleep-disordered breathing, hypoxia, and risk of mild cognitive impairment and dementia in older women. JAMA 2011;306(6):613-9. PMID 21828324
104: Yaggi HK, Concato J, Kernan WN, Lichtman JH, Brass LM, Mohsenin V. Obstructive sleep apnea as a risk factor for stroke and death. N Engl J Med 2005;353:2034-41. PMID 16282178
105: Yeboah J, Redline S, Johnson C, et al. Association between sleep apnea, snoring, incident cardiovascular events and all-cause mortality in an adult population: MESA. Atherosclerosis 2011;219:963-8. PMID 22078131
106: Zhang CE, Wong SM, van de Haar HJ, et al. Blood-brain barrier leakage is more widespread in patients with cerebral small vessel disease. Neurology 2017a;88(5):426-32. PMID 28031395
107: Zhang Y, Wang W, Cai S, et al. Obstructive sleep apnea exaggerates cognitive dysfunction in stroke patients. Sleep Med 2017b;33:183-90. PMID 28291701
108: Zhu RL, Ouyang C, Ma RL, Wang K. Obstructive sleep apnea is associated with cognitive impairment in minor ischemic stroke. Sleep Breath 2022;26(4):1907-14. PMID 35305233
109: Zunzunegui C, Gao B, Cam E, Hodor A, Bassetti CL. Sleep disturbance impairs stroke recovery in the rat. Sleep 2011;34:1261-9. PMID 21886364

Patient Profile

Age range of presentation: 19 to 65+ years
Sex preponderance: male=female
Heredity: none
Population groups selectively affected: none selectively affected
Occupation groups selectively affected: none selectively affected

ICD & OMIM codes

ICD-10: Sleep apnea: G47.3

Mood (affective) disorders: F30-F39

Other specified extrapyramidal and movement disorders: G25.8

Cerebrovascular accident NOS: I64
ICD-11: Obstructive sleep apnoea: 7A41

Dementia due to cerebrovascular disease: 6D81

Secondary mood syndrome: 6E62

Stroke not known if ischaemic or haemorrhagic: 8B20

This is an article preview.
Start a Free Account
to access the full version.

Nearly 3,000 illustrations, including video clips of neurologic disorders.
Every article is reviewed by our esteemed Editorial Board for accuracy and currency.
Full spectrum of neurology in 1,200 comprehensive articles.
Listen to MedLink on the go with Audio versions of each article.

Questions or Comment?

MedLink®, LLC

3525 Del Mar Heights Rd, Ste 304
San Diego, CA 92130-2122

Toll Free (U.S. + Canada): 800-452-2400

US Number: +1-619-640-4660

Support: service@medlink.com

Editor: editor@medlink.com

ISSN: 2831-9125

Sleep, stroke, and vascular dementia

Associated Disorders

Sleep apnea associated with stroke

Differential Diagnosis

lesions of the right parietal lobe
lesions of deep white matter
frontal lobe damage
cerebral edema
poststroke depression
- metabolic conditions
- toxic conditions
- narcolepsy
- periodic limb movements
- congestive heart failure

Also Relevant

Central sleep apnea
Depression after stroke
Medical complications of stroke
Obstructive sleep apnea
Sleep disorders
- Sleep and cardiac disorders
- Sleep and medical disorders

Sleep, stroke, and vascular dementia

Sleep, stroke, and vascular dementia

Introduction

Overview

Key points

Historical note and terminology

Clinical manifestations

Presentation and course

Prognosis and complications

Clinical vignette

Biological basis

Etiology and pathogenesis

Epidemiology

Prevention

Differential diagnosis

Diagnostic workup

Management

Special considerations

Anesthesia

Media

References

Contributors

Author

Former Authors

Patient Profile

ICD & OMIM codes

This is an article preview.
Start a Free Account
to access the full version.

Questions or Comment?

Also in This Category

Telehealth and cognitive behavioral therapy for insomnia (CBT-I)

NonREM parasomnias

Neurologic disorders associated with obesity

Hypersomnolence

Ischemic stroke

Cerebral embolism

Hormonal contraception and stroke

Antiphospholipid antibody syndrome

Sleep, stroke, and vascular dementia

Introduction

Overview

Key points

Historical note and terminology

Clinical manifestations

Presentation and course

Prognosis and complications

Clinical vignette

Biological basis

Etiology and pathogenesis

Epidemiology

Prevention

Differential diagnosis

Diagnostic workup

Management

Special considerations

Anesthesia

Media

References

Contributors

Author

Former Authors

Patient Profile

ICD & OMIM codes

This is an article preview. Start a Free Account to access the full version.

Questions or Comment?

Also in This Category

Telehealth and cognitive behavioral therapy for insomnia (CBT-I)

NonREM parasomnias

Neurologic disorders associated with obesity

Hypersomnolence

Ischemic stroke

Cerebral embolism

Hormonal contraception and stroke

Antiphospholipid antibody syndrome

This is an article preview.
Start a Free Account
to access the full version.